Barraclough JY - Search Results

1

Neutrophil-derived microparticles are released into the coronary circulation following percutaneous coronary intervention in acute coronary syndrome patients.

Martínez GJ, Barraclough JY, Nakhla S, Kienzle V, Robertson S, Mallat Z, Celermajer DS, Patel S. Martínez GJ, et al. Among authors: barraclough jy. Biosci Rep. 2017 Jan 17;37(1):BSR20160430. doi: 10.1042/BSR20160430. Print 2017 Feb 28. Biosci Rep. 2017. PMID: 27913753 Free PMC article.

2

Colchicine Acutely Suppresses Local Cardiac Production of Inflammatory Cytokines in Patients With an Acute Coronary Syndrome.

Martínez GJ, Robertson S, Barraclough J, Xia Q, Mallat Z, Bursill C, Celermajer DS, Patel S. Martínez GJ, et al. J Am Heart Assoc. 2015 Aug 24;4(8):e002128. doi: 10.1161/JAHA.115.002128. J Am Heart Assoc. 2015. PMID: 26304941 Free PMC article. Clinical Trial.

3

Colchicine therapy in acute coronary syndrome patients acts on caspase-1 to suppress NLRP3 inflammasome monocyte activation.

Robertson S, Martínez GJ, Payet CA, Barraclough JY, Celermajer DS, Bursill C, Patel S. Robertson S, et al. Among authors: barraclough jy. Clin Sci (Lond). 2016 Jul 1;130(14):1237-46. doi: 10.1042/CS20160090. Epub 2016 Apr 21. Clin Sci (Lond). 2016. PMID: 27129183 Free article. Clinical Trial.

4

Sex differences in aortic augmentation index in adolescents.

Barraclough JY, Garden FL, Toelle B, O'Meagher S, Marks GB, Cowell CT, Celermajer DS, Ayer JG. Barraclough JY, et al. J Hypertens. 2017 Oct;35(10):2016-2024. doi: 10.1097/HJH.0000000000001425. J Hypertens. 2017. PMID: 28590266

5

Transcoronary gradients of HDL-associated MicroRNAs in unstable coronary artery disease.

Choteau SA, Cuesta Torres LF, Barraclough JY, Elder AMM, Martínez GJ, Chen Fan WY, Shrestha S, Ong KL, Barter PJ, Celermajer DS, Rye KA, Patel S, Tabet F. Choteau SA, et al. Among authors: barraclough jy. Int J Cardiol. 2018 Feb 15;253:138-144. doi: 10.1016/j.ijcard.2017.09.190. Int J Cardiol. 2018. PMID: 29306454

6

Early and late childhood telomere length predict subclinical atherosclerosis at age 14 yrs. - The CardioCAPS study.

Barraclough JY, Skilton MR, Garden FL, Toelle BG, Marks GB, Celermajer DS. Barraclough JY, et al. Int J Cardiol. 2019 Mar 1;278:250-253. doi: 10.1016/j.ijcard.2018.12.065. Epub 2018 Dec 22. Int J Cardiol. 2019. PMID: 30595356

7

Weight Gain Trajectories from Birth to Adolescence and Cardiometabolic Status in Adolescence.

Barraclough JY, Garden FL, Toelle BG, Marks GB, Baur LA, Ayer JG, Celermajer DS. Barraclough JY, et al. J Pediatr. 2019 May;208:89-95.e4. doi: 10.1016/j.jpeds.2018.12.034. Epub 2019 Feb 6. J Pediatr. 2019. PMID: 30738659

8

Colchicine as a Novel Therapy for Suppressing Chemokine Production in Patients With an Acute Coronary Syndrome: A Pilot Study.

Tucker B, Kurup R, Barraclough J, Henriquez R, Cartland S, Arnott C, Misra A, Martínez G, Kavurma M, Patel S. Tucker B, et al. Clin Ther. 2019 Oct;41(10):2172-2181. doi: 10.1016/j.clinthera.2019.07.015. Epub 2019 Aug 10. Clin Ther. 2019. PMID: 31409556 Clinical Trial.

9

MicroRNAs as Prognostic Markers in Acute Coronary Syndrome Patients-A Systematic Review.

Barraclough JY, Joan M, Joglekar MV, Hardikar AA, Patel S. Barraclough JY, et al. Cells. 2019 Dec 4;8(12):1572. doi: 10.3390/cells8121572. Cells. 2019. PMID: 31817254 Free PMC article.

10

A MicroRNA Signature in Acute Coronary Syndrome Patients and Modulation by Colchicine.

Barraclough JY, Joglekar MV, Januszewski AS, Martínez G, Celermajer DS, Keech AC, Hardikar AA, Patel S. Barraclough JY, et al. J Cardiovasc Pharmacol Ther. 2020 Sep;25(5):444-455. doi: 10.1177/1074248420922793. Epub 2020 May 1. J Cardiovasc Pharmacol Ther. 2020. PMID: 32356454

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23 results

Search Page

Filters